Immunohistochemical distribution of the secretogranin II-derived peptide EM66 in the rat hypothalamus: A comparative study with jerboa

Neuroscience Letters

Volumn 414, Issue 3, 2007, Pages 268-272

  Boutahricht, Mohammed ^a   Guillemot, Johann ^b   Montero Hadjadje, Maité ^b   Barakat, Youssef ^a   El Ouezzani, Seloua ^a   Alaoui, Abdelilah ^a   Yon, Laurent ^b   Vaudry, Hubert ^b   Anouar, Youssef ^b   Magoul, Rabia ^a  

^a Université Sidi Mohammed Ben Abdellah   (Morocco)

^b Europ Inst Peptide Res IFRMP 23   (France)

Author keywords

EM66 peptide; Hypothalamus; Jerboa; Rat; Secretogranin II

Indexed keywords

EM66 PEPTIDE; PEPTIDE; SECRETOGRANIN II; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ANTIBODY LABELING; ARCUATE NUCLEUS; ARTICLE; BIOLOGICAL RHYTHM; CELLULAR DISTRIBUTION; CONTROLLED STUDY; FEEDING BEHAVIOR; FEMALE; FOOD INTAKE; HOMEOSTASIS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; JACULUS ORIENTALIS; LATERAL HYPOTHALAMUS; MALE; NERVE CELL; NEUROENDOCRINE SYSTEM; NONHUMAN; PREOPTIC AREA; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; RODENT; SPECIES DIFFERENCE; SUPRACHIASMATIC NUCLEUS; SUPRAOPTIC NUCLEUS;

ANIMALS; BRAIN MAPPING; FEEDING BEHAVIOR; FEMALE; HOMEOSTASIS; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; MALE; NEURONS; NEUROPEPTIDES; NEUROSECRETORY SYSTEMS; PEPTIDE FRAGMENTS; PERIODICITY; RATS; RATS, WISTAR; RODENTIA; SECRETOGRANIN II; SPECIES SPECIFICITY; WATER-ELECTROLYTE BALANCE;

EID: 33847295611     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.12.033     Document Type: Article

References (25)

1. Agneter E., Sitte H.H., Stockl-Hiesleitner S., Fischer-Colbrie R., Winkler H., and Singer E.A. Sustained dopamine release induced by secretoneurin in the striatum of the rat: a microdialysis study. J. Neurochem. 65 (1995) 622-625
2. Anouar Y., Jegou S., Alexandre D., Lihrmann I., Conlon J.M., and Vaudry H. Molecular cloning of frog secretogranin II reveals the occurrence of several highly conserved potential regulatory peptides. FEBS Lett. 394 (1996) 295-299
3. Anouar Y., Yon L., Desmoucelles C., Leprince J., Breault L., Gallo-Payet N., and Vaudry H. Identification of a novel secretogranin II-derived peptide in the adult and fetal human adrenal gland. Endocr. Res. 24 (1998) 731-736
4. Bartanusz V., Aubry J.M., Jezova D., Baffi J., and Kiss J.Z. Up-regulation of vasopressin mRNA in paraventricular hypophysiotrophic neurons after acute immobilization stress. Neuroendocrinology 58 (1993) 625-629
5. Boutahricht M., Guillemot J., Montero-Hadjadje M., Bellafqih S., El Ouezzani S., Alaoui A., Yon L., Vaudry H., Anouar Y., and Magoul R. Biochemical characterisation and immunohistochemical localisation of the secretogranin II-derived peptide EM66 in the hypothalamus of the jerboa (Jaculus orientalis): modulation by food deprivation. J. Neuroendocrinol. 17 (2005) 372-378
6. Ceccatelli S., Eriksson M., and Hokfelt T. Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin- and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocrinology 49 (1989) 309-323
7. Fischer-Colbrie R., Laslop A., and Kirchmair R. Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin. Prog. Neurobiol. 46 (1995) 49-70
8. Gasser M.C., Berti I., Hauser K.F., Fischer-Colbrie R., and Saria A. Secretoneurin promotes pertussis toxin-sensitive neurite outgrowth in cerebellar granule cells. J. Neurochem. 85 (2003) 662-669
9. Kim E.M., Welch C.C., Grace M.K., Billington C.J., and Levine A.S. Effects of palatability-induced hyperphagia and food restriction on mRNA levels of neuropeptide-Y in the arcuate nucleus. Brain Res. 806 (1998) 117-121
10. Kirchmair R., Hogue-Angeletti R., Gutierrez J., Fischer-Colbrie R., and Winkler H. Secretoneurin-a neuropeptide generated in brain, adrenal medulla and other endocrine tissues by proteolytic processing of secretogranin II (chromogranin C). Neuroscience 53 (1993) 359-365
11. Leitner B., Fischer-Colbrie R., Scherzer G., and Winkler H. Secretogranin II: relative amounts and processing to secretoneurin in various rat tissues. J. Neurochem. 66 (1996) 1312-1317
12. Magoul R., Dubourg P., Benjelloun W., and Tramu G. Synaptic inputs of tachykinin-containing nerve terminals to target tyrosine-hydroxylase-, beta-endorphin- and neuropeptide Y-producing neurons of the arcuate nucleus. Double pre-embedding immunocytochemical study in the rat. J. Chem. Neuroanat. 6 (1993) 419-429
13. Montero-Hadjadje M., Pelletier G., Yon L., Li S., Guillemot J., Magoul R., Tillet Y., Vaudry H., and Anouar Y. Biochemical characterization and immunocytochemical localization of EM66, a novel peptide derived from secretogranin II, in the rat pituitary and adrenal glands. J. Histochem. Cytochem. 51 (2003) 1083-1095
14. Montero-Hadjadje M., Ait-Ali D., Turquier V., Guillemot J., Boutahricht M., Magoul R., Malagon M.M., Yon L., Vaudry H., and Anouar Y. Chromogranins/secretogranins and derived peptides: insights from the amphibian model. In: Kastin A.J. (Ed). The Handbook of Biologically Active Peptides (2006), Elsevier, New York 311-319
15. Paulmyer-Lacroix O., Guillaume V., Anglade G., Grino M., and Oliver C. Regulation of corticotropic function in stressful situations. Ann. Endocrinol. (Paris) 56 (1995) 245-251
16. Paxinos G., and Watson C. The Rat Brain in Stereotaxic Coordinates (1986), Academic, San Diego
17. Shu S.Y., Ju G., and Fan L.Z. The glucose oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett. 85 (1988) 169-171
18. Swanson L.W., Sawchenko P.E., and Lind R.W. Regulation of multiple peptides in CRF parvocellular neurosecretory neurons: implications for the stress response. Prog. Brain Res. 68 (1986) 169-190
19. Turquier V., Yon L., Grumolato L., Alexandre D., Fournier A., Vaudry H., and Anouar Y. Pituitary adenylate cyclase-activating polypeptide stimulates secretoneurin release and secretogranin II gene transcription in bovine adrenochromaffin cells through multiple signaling pathways and increased binding of pre-existing activator protein-1-like transcription factors. Mol. Pharmacol. 60 (2001) 42-52
20. Urban J.H., Bauer-Dantoin A.C., and Levine J.E. Neuropeptide Y gene expression in the arcuate nucleus: sexual dimorphism and modulation by testosterone. Endocrinology 132 (1993) 139-145
21. Vaudry H., and Conlon J.M. Identification of a peptide arising from the specific post-translation processing of secretogranin II. FEBS Lett. 284 (1991) 31-33
22. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog. Neurobiol. 40 (1993) 573-629
23. Yajima A., Ikeda M., Miyazaki K., Maeshima T., Narita N., and Narita M. Manserin, a novel peptide from secretogranin II in the neuroendocrine system. Neuroreport 15 (2004) 1755-1759
24. Yon L., Guillemot J., Montero-Hadjadje M., Grumolato L., Leprince J., Lefebvre H., Contesse V., Plouin P.F., Vaudry H., and Anouar Y. Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors. J. Clin. Endocrinol. Metab. 88 (2003) 2579-2585
25. Zaborszkhy L. Afferent Connections of the Medial Basal Hypothalamus (1982), Springer-Verlag, New York